EHC vs. ALC, THC, UHS, ENSG, ACHC, SEM, BKD, USPH, WOOF, and CYH
Should you be buying Encompass Health stock or one of its competitors? The main competitors of Encompass Health include Alcon (ALC), Tenet Healthcare (THC), Universal Health Services (UHS), The Ensign Group (ENSG), Acadia Healthcare (ACHC), Select Medical (SEM), Brookdale Senior Living (BKD), U.S. Physical Therapy (USPH), Petco Health and Wellness (WOOF), and Community Health Systems (CYH). These companies are all part of the "health care facilities" industry.
Encompass Health vs. Its Competitors
Encompass Health (NYSE:EHC) and Alcon (NYSE:ALC) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation, risk and media sentiment.
In the previous week, Encompass Health had 2 more articles in the media than Alcon. MarketBeat recorded 11 mentions for Encompass Health and 9 mentions for Alcon. Encompass Health's average media sentiment score of 1.24 beat Alcon's score of 0.31 indicating that Encompass Health is being referred to more favorably in the media.
Encompass Health has a beta of 0.88, meaning that its share price is 12% less volatile than the S&P 500. Comparatively, Alcon has a beta of 0.95, meaning that its share price is 5% less volatile than the S&P 500.
97.3% of Encompass Health shares are owned by institutional investors. Comparatively, 53.9% of Alcon shares are owned by institutional investors. 2.0% of Encompass Health shares are owned by company insiders. Comparatively, 1.5% of Alcon shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Encompass Health currently has a consensus target price of $131.50, indicating a potential upside of 11.84%. Alcon has a consensus target price of $106.13, indicating a potential upside of 19.62%. Given Alcon's higher possible upside, analysts plainly believe Alcon is more favorable than Encompass Health.
Alcon has higher revenue and earnings than Encompass Health. Encompass Health is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks.
Alcon has a net margin of 11.28% compared to Encompass Health's net margin of 8.97%. Encompass Health's return on equity of 17.63% beat Alcon's return on equity.
Summary
Encompass Health and Alcon tied by winning 8 of the 16 factors compared between the two stocks.
Get Encompass Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for EHC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding EHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Encompass Health Competitors List
Related Companies and Tools
This page (NYSE:EHC) was last updated on 7/10/2025 by MarketBeat.com Staff
Free EHC Stock Alerts